Mesoblast Limited IPO Info

Company Name: Mesoblast Limited
Stock Symbol: MESO
Exchange: NASDAQ
Status: Priced
IPO Date: 11/13/2015
IPO Price: 8.00 (-20.50%)

Underwriters

J.P. Morgan and Credit Suisse

Amount of Offering: N/A
Number of Shares Offered: 7.48 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A

Company Description

Mesoblast has established a diverse portfolio of product candidates based on its proprietary allogeneic, off-the-shelf mesenchymal lineage cell-based technology, with multiple active Phase 3 clinical programs. Mesoblast's lead product candidates target major diseases with significant unmet medical needs despite existing therapies. These include chronic heart failure, chronic low back pain due to degenerative disc disease, and immune-mediated conditions such as acute graft versus host disease and biologic refractory rheumatoid arthritis.

News Headlines

• Mesoblast (MESO) IPO Opens Lower, Trades Back Above Flat-line
• Mesoblast (MESO) Prices 7.5M ADS Offering at $8/ADS